iCureASPS Fundraising

Thank You Somerset Middle School!

Dear iCureASP Community, I would like to thank the special students and teachers at Somerset Middle School in Wisconsin for their act of kindness and generosity. They made a decision to support the search for the much needed cure for Alveolar Soft Part Sarcoma. Recently in my mailbox I found a donation with the following kind […]

Donate now and support the development of cure for ASPS

We are opening iCureASPS annual fundraiser with the traditional PMC bike ride. Our ASPS team rides yesterday and today for the 10th year at the Pan-Massachusetts Challenge (PMC). Ten years have passed since we founded our group and started to look for a cure for Alveolar Soft Part Sarcoma (ASPS), a rare cancer that has […]

A Summary of Phase II Cederanib Clinical Trial

The summary of the phase 2 clinical trial of Cediranib on Alveolar Soft Part Sarcoma was recently published in the “Journal of Clinical Oncology” by Shivaani Kummar and others from the National Cancer Institute and the Frederick National Laboratory for Cancer Research. The authors report that Cediranib has substantial single-agent activity, producing an objective response […]

In Honor of Patti Spires 1967-2012

Patti Spires Hamilton was born at Ft. Meade, Maryland, on September 3, 1967, and passed away in Houston, TX on August 20, 2012. Her life was cut short by Alveolar Soft Part Sarcoma (ASPS), unfortunately undetected and unrecognized by the physicians who treated her for various other “ailments” during the past several years. Patti was […]

Update on the Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

If you consider to join the following clinical trial: Sunitinib or Cediranib for Alveolar Soft Part Sarcoma ; study NCT01391962 Please note that patients can join only if: ·        Patients show evidence of disease progression ·        Patients must not have received prior treatment with any VEGF receptor tyrosine kinase inhibitor (e.g., cediranib, sunitinib, pazopanib, sorafenib); […]

Important Update on Cediranib development for Alveolar Soft Part Sarcoma (ASPS)

Dear ASPS community. Many of our patients who participated in Cediranib clinical trials reported on our FORUM positive ASPS response to the drug. The conclusion that Cediranib shows favorable activity in ASPS is detailed in a summary of a Phase 2 clinical trial by Dr. Kummar in the 2011 meeting of the American Society of […]

Happy New Year 2012!

Dear ASPS community, iCureASPS is wishing you all Happy 2012! We would like to thank our “Team ASPS” for the PMC bike ride. Our team has just completed another successful year of fundraiser, following their ride in August.  It is the 8th year that Team ASPS participates in the Pan-Massachusetts Challenge, a bike -a-thon that […]

Update on the Cediranib and Sunitinib Clinical Trials for Alveolar Soft Part Sarcoma Phase II in the USA

  Please note the two Phase II clinical trials available for ASPS patients in the US: 1.   Sunitinib or Cediranib for Alveolar Soft Part Sarcoma, study number NCT01391962 Contact: NCI Referral Office, Tel.   1-888-NCI-1937 Locations: United States, California Santa Monica Oncology Center Santa Monica, California, United States, 90403 United States, Maryland National Institutes of Health […]